Board of Directors

Quality Insights Renal Network 5 is governed by its Board of Directors, which consists of up to 15 members.  The Board provides leadership and oversight of:  the strategic direction of the organization; performance of management staff in meeting ESRD network contract requirements and deliverables; activities and recommendations of the Network Council, Medical Review Board and Patient Advisory Committee; the financial operation of the Network; and corporate compliance.
The membership of the Board of Directors includes representatives of a variety of health care settings and disciplines relevant to the ESRD population, which may include hospitals, dialysis centers, nursing homes, home health, hospice, dialysis patients and other consumers, physicians, and other clinical and administrative professionals.  Members are selected to be broadly representative of the network service area.
Directors are appointed for three-year terms and generally may serve no more than two consecutive terms.  Terms are staggered so that approximately one-third of the directors are appointed each year. Directors are appointed by the Quality Insights, Inc. Board of Directors at the first meeting of the calendar year, or otherwise as vacancies arise. Network 5 directors are not compensated for Board service other than reimbursement of travel-related expenses.

If you are interested in becoming a member of the Board of Directors, please contact Brandy Vinson at (804) 320-0004 ext. 2711 or




Sven T. Berg, MD, MPH, CPE
CEO – Quality Insights
Charleston, WV
Appointed: Ex Officio, Unlimited Term

Stephen Seliger, MD, Chair
Associate Professor
University of Maryland, Baltimore
Baltimore, Maryland 
Appointed: 2020, 3-year term

Marc Brazie, MD, Vice Chair, MRB Chair
Clinton, MD
Appointed: 2020, 3-year term

Matthew Cooper, MD 
Transplant Surgeon
Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital
Washington, DC
Appointed: 2018, 3-year term

Elizabeth Jones, MSW, LCSW, FNKF
Social Worker
Sterling, VA
Appointed: 2020, 3-year term

Susie Lew, MD
George Washington University
Washington, DC
Appointed: 2019, 3-year term

April McGraw, RN 
Dialysis Administrator
Williamsburg, VA
Appointed: 2018, 3-year term

Rebecca Schmidt, DO, FACP, FASN 
Professor of Medicine
West Virginia University
Morgantown, WV
Appointed: 2018, 3-year term

Heather Weirich, BSN, RN, CNN
Baltimore, MD
Appointed: 2020, 3-year term

David White
Medicare Beneficiary
Hillcrest Heights, Maryland
Appointed: 2019, 3-year term

Board Committees


The Board of Directors has established an Executive Committee and a Compliance Committee.  The Executive Committee is empowered to act between regular Board meetings consistent with the direction of the full Board.  The Executive Committee may also assist in identifying potential new director candidates.  The Executive Committee is comprised of the officers of the Board (chair and vice chair) and such other directors as the Board may appoint.


The Compliance Committee provides oversight of the corporate ethics and compliance program as it relates to Quality Insights Renal Network 5.  It receives regular reports from the corporate compliance officer and is notified of any significant instances of non-compliance with contractual or other legal obligations.  The Compliance Committee consists of the officers of the Board and such other directors as the Board may appoint.  A majority must be independent directors.